1 / 12

Medicine price survey in Lebanon, 2004 undertaken by Dr Rita Karam, Ministry of Health

Medicine price survey in Lebanon, 2004 undertaken by Dr Rita Karam, Ministry of Health. Marg Ewen (on behalf of Dr Karam) WHO/HAI post-medicine price survey regional workshop, Cairo 7-9 January 2007. Population in millions: 4 (excluding foreign residents & refugees)

vicky
Download Presentation

Medicine price survey in Lebanon, 2004 undertaken by Dr Rita Karam, Ministry of Health

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Medicine price survey in Lebanon, 2004undertaken by Dr Rita Karam, Ministry of Health Marg Ewen (on behalf of Dr Karam) WHO/HAI post-medicine price survey regional workshop, Cairo 7-9 January 2007 Lebanon, 2004

  2. Population in millions: 4 (excluding foreign residents & refugees) % of rural population: 85 % Total adult literacy rate: 88 % GDP per capita: 5611 US $ Total health expenditure: 10.4 % of GDP Government health expenditure 29.3% of total health expenditure Public sector – medicines supplied by MoH (free) and NSSF (75-80% of patient price reimbursed) Country background Lebanon, 2004

  3. Methodology • Number of medicines surveyed: 32 • Core 26 Supplementary 6 • Year of MSH reference price used: 2002 • Number of regions surveyed: 4 • Total number of facilities sampled: Lebanon, 2004

  4. Availability Lebanon, 2004

  5. Prices: summary MPRs and examples IB = innovator brand LPG = lowest priced generic Lebanon, 2004

  6. Affordability (No. of days’ wages) Lebanon, 2004

  7. Price components Lebanon, 2004

  8. Main Findings • Public sector procurement prices vary from acceptable to high • Availability of medicines in the public sector is extremely poor • Availability of medicines in private retail pharmacies is good • Prices are very high for both generics and innovator brands in the private sector Lebanon, 2004

  9. Recommendations • Develop a National Drug Policy • Annual budget allocation for essential medicines in the public sector • Unify public sector procurement, use tenders • Streamline the public sector supply system • Review the pricing scheme in order to lower prices • Permit and encourage generic substitution Lebanon, 2004

  10. Follow-up activities 2004: • Committee of 4 pharmacists compared FOB prices of about 2200 imported medicines with prices paid by Saudi Arabia & Jordan. Outcome: 1100 meds (25% of all registered medicines) had FOB price reduced by 20-30% • Budget increased for cancer, HIV & other specialised medicines from $14M per annum to $40M Lebanon, 2004

  11. 2005: Implemented a new pricing structure for all imported medicines, estimated to reduce patient prices by 3-15% Lebanon, 2004

  12. 2006: Information on patient prices & pharmacy margin included on MoH website. Updated every 2 weeks. 2007: • First Lebanese National Formulary to be distributed in April to all doctors & pharmacists. Comparative information on brand/generic products registered in Lebanon, strength/dosage form, country of origin, price and coverage by NSSF. To be updated annually. • Project to review price structure of locally manufactured medicines (700, generics, prices quite low) 2008/2009: Implementing a re-pricing scheme for all medicines – reducing the FOB price Lebanon, 2004

More Related